Most Read Articles
05 Nov 2019
Low total cholesterol levels appear to carry increased major adverse cardiovascular events (MACE) hazard in older men without ischaemic heart disease (IHD) and not receiving statin therapy but not to those on statins, according to data from the CHAMP (Concord Health and Ageing in Men Project) cohort.
2 days ago
Better sleep appears to weaken pain and fatigue in older, community-dwelling adults with hip or knee osteoarthritis (OA), reports a recent study.
6 days ago
Maribavir 400 mg twice daily appears to have comparable efficacy to valganciclovir at clearing cytomegalovirus viraemia in transplant recipients, a study has found.
5 days ago
Individuals with and without gout appear to have a similar risk of developing colorectal cancer, suggesting that gout does not contribute to a risk increase, a study has found.

Add-on diclofenac better than monotherapy for managing acute lower back pain

08 Oct 2019

Using diclofenac in combination with TPC (thiamine, pyridoxine and cyanocobalamin) offers superior analgesic effect than diclofenac monotherapy in the management of acute lower back pain (LBP), according to a systematic review and meta-analysis.

Researchers searched multiple online databases for studies evaluating the efficacy of diclofenac used with TPC vs alone (control) for pain management in patients with acute or chronic LBP (primary or secondary; of mild, moderate or severe intensity; and nociceptive, neuropathic or nociplastic in nature). They evaluated the risk of bias regarding randomization, allocation concealment, blinding, incomplete outcome data, selective reporting and other biases.

The search yielded five studies involving 1,108 adult patients in total. Four of these studies used the primary outcome of premature discontinuation of treatment due to complete relief of pain. The quality of evidence was rated as moderate-to-high.

Pooled data showed that more patients who received the combination therapy vs diclofenac monotherapy achieved the primary outcome (189 of 548 vs 128 of 560 patients; risk difference, 12 percent, 95 percent CI, 4–20; p=0.003; relative risk, 1.52, 1.19–1.93; p=0.0007).

Patients who received diclofenac plus TPC were 87 percent as likely as those treated with diclofenac monotherapy to achieve pain relief (odds ratio, 1.87, 1.28–2.72; p=0.001; number needed to treat to benefit, 9, 6–16).

The researchers noted the need for more studies to confirm the safety of diclofenac plus TPC, as well as to examine TPC as a new analgesic adjuvant therapy in several types of pain such as mixed pain syndromes, osteoarthritis, postoperative pain and cancer, among others.  

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
05 Nov 2019
Low total cholesterol levels appear to carry increased major adverse cardiovascular events (MACE) hazard in older men without ischaemic heart disease (IHD) and not receiving statin therapy but not to those on statins, according to data from the CHAMP (Concord Health and Ageing in Men Project) cohort.
2 days ago
Better sleep appears to weaken pain and fatigue in older, community-dwelling adults with hip or knee osteoarthritis (OA), reports a recent study.
6 days ago
Maribavir 400 mg twice daily appears to have comparable efficacy to valganciclovir at clearing cytomegalovirus viraemia in transplant recipients, a study has found.
5 days ago
Individuals with and without gout appear to have a similar risk of developing colorectal cancer, suggesting that gout does not contribute to a risk increase, a study has found.